These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 478046)

  • 21. Spironolactone treatment in scleroderma--a double-blind therapy study.
    Altmeyer P; Goerz G; Hammer H; Holzmann H; Krieg T; Luderschmidt C; Meigel WN; Mensing H
    Dermatologica; 1985; 171(5):374-5. PubMed ID: 3908176
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature].
    Marrakchi H; Fazaa B; Gorgi Y; Jellouli A; Mokhtar I; Kamoun MR
    Tunis Med; 1995 Feb; 73(2):149-52. PubMed ID: 9506158
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colchicine therapy for familial mediterranean fever. A double-blind trial.
    Dinarello CA; Wolff SM; Goldfinger SE; Dale DC; Alling DW
    N Engl J Med; 1974 Oct; 291(18):934-7. PubMed ID: 4606353
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of systemic sclerosis.
    Medsger TA
    Ann Rheum Dis; 1991 Nov; 50 Suppl 4(Suppl 4):877-86. PubMed ID: 1750801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.
    Seibold JR; Korn JH; Simms R; Clements PJ; Moreland LW; Mayes MD; Furst DE; Rothfield N; Steen V; Weisman M; Collier D; Wigley FM; Merkel PA; Csuka ME; Hsu V; Rocco S; Erikson M; Hannigan J; Harkonen WS; Sanders ME
    Ann Intern Med; 2000 Jun; 132(11):871-9. PubMed ID: 10836913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study.
    Goldstein RC; Schwabe AD
    Ann Intern Med; 1974 Dec; 81(6):792-4. PubMed ID: 4611296
    [No Abstract]   [Full Text] [Related]  

  • 28. Colchicine revisited.
    Bhat A; Naguwa SM; Cheema GS; Gershwin ME
    Ann N Y Acad Sci; 2009 Sep; 1173():766-73. PubMed ID: 19758227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.
    Knobler RM; French LE; Kim Y; Bisaccia E; Graninger W; Nahavandi H; Strobl FJ; Keystone E; Mehlmauer M; Rook AH; Braverman I;
    J Am Acad Dermatol; 2006 May; 54(5):793-9. PubMed ID: 16635659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of scleroderma.
    Barnett AJ
    Med J Aust; 1977 Jul; 2(3):105-6. PubMed ID: 331045
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of cirrhosis with colchicine. A double-blind randomized trial.
    Kershenobich D; Uribe M; Suárez GI; Mata JM; Pérez-Tamayo R; Rojkind M
    Gastroenterology; 1979 Sep; 77(3):532-6. PubMed ID: 378754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).
    Fries JF; Wasner C; Brown J; Feigenbaum P
    Ann Rheum Dis; 1984 Jun; 43(3):407-10. PubMed ID: 6378105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of generalized scleroderma with factor XIII. Study of 25 cases].
    Guillevin L; Chouvet B; Mery C; Thivolet J; Godeau P; Delbarre F
    Rev Med Interne; 1982; 3(3):273-7. PubMed ID: 6758093
    [No Abstract]   [Full Text] [Related]  

  • 35. Progressive systemic sclerosis (diffuse scleroderma). A follow-up report of treatment with potaba.
    Silber W; Gitlin N
    S Afr Med J; 1973 Jun; 47(23):1001-2. PubMed ID: 4576830
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma].
    Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM
    Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind randomized controlled trial of ketotifen versus placebo in early diffuse scleroderma.
    Gruber BL; Kaufman LD
    Arthritis Rheum; 1991 Mar; 34(3):362-6. PubMed ID: 2003858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reynold's syndrome. A case report (author's transl)].
    Alcocer J; Herrera R; Lavalle C; Gudiño J; Fraga A
    Rev Gastroenterol Mex; 1978; 43(1):1-8. PubMed ID: 715342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.
    Furst DE; Clements PJ; Hillis S; Lachenbruch PA; Miller BL; Sterz MG; Paulus HE
    Arthritis Rheum; 1989 May; 32(5):584-93. PubMed ID: 2655606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiclinic study of DMSO for systemic sclerosis.
    Scherbel AL
    Arthritis Rheum; 1985 Dec; 28(12):1437-8. PubMed ID: 3910051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.